CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −780 | $572.17 | $446K | 48,268 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −677 | $573.46 | $388K | 47,591 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,267 | $574.31 | $728K | 46,324 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $575.38 | $391K | 45,644 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −250 | $576.55 | $144K | 45,394 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,217 | $577.39 | $703K | 44,177 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,653 | $578.48 | $956K | 42,524 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −678 | $579.37 | $393K | 41,846 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −504 | $580.22 | $292K | 41,342 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −829 | $581.68 | $482K | 40,513 |
| 2026-05-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 53,288 | ||
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $568.60 | $45K | 28,796 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −80 | $570.06 | $46K | 28,716 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $571.00 | $23K | 28,676 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −480 | $572.40 | $275K | 28,196 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −153 | $573.82 | $88K | 28,043 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −487 | $574.84 | $280K | 27,556 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,436 | $575.75 | $1.4M | 25,120 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,005 | $576.66 | $1.7M | 22,115 |
Page 111 of 121 · 2,404 trades